Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and IndiaNCT03491735
Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018
An observational study of Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India, run by Kasr El Aini Hospital at 2 sites in 2 countries.
Trial summary
In this study, we are aiming to identify the patterns of glaucoma observed and treated at Glaucoma Subspecialty Clinics of Kasr Al-Aini Hospital, Cairo University in Cairo, Egypt and corresponding clinics in Sadguru Netra Chikitsalaya Post Graduate Institute of Ophthalmology in Mumbai, Maharashtra, India during the… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India
- What is being tested?
- collection of data from patient files
- How many people
- 2,500 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 1 Jan 2018to 31 Dec 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients referred to and following up in the glaucoma sub-specialty clinics in the year 2018 in two centres: Kasr Al-Aini Hospital in Cairo and Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology in India
Who may be able to join
- All patients referred to glaucoma sub-specialty clinics in the year 2018 in two centres: Kasr Al-Aini Hospital in Cairo and Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology in India
Who cannot join
- Patients younger than 18 years old.
- Patients with incomplete examination data
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Egypt1 site, 1 recruiting
- Recruiting
Kasr Al-Aini Hospital, Cairo University
Cairo, 11562
Rana H Amin, M.Sc., 00201276020720, rana_hussein4@hotmail.com
Ahmed M Abdel-Rahman, M.D., 00201227394861, ahmed.mostafa@kasralainy.edu.eg
India1 site, 1 recruiting
- Recruiting
two centres: Kasr Al-Aini Hospital in Cairo and Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology
Mumbai, 400020
Rakesh Shakya, M.D.
About this study
In this study, we are aiming to identify the patterns of glaucoma observed and treated at Glaucoma Subspecialty Clinics of Kasr Al-Aini Hospital, Cairo University in Cairo, Egypt and corresponding clinics in Sadguru Netra Chikitsalaya Post Graduate Institute of Ophthalmology in Mumbai, Maharashtra, India during the year 2018. We are hoping that this study would provide an update on current statistics available on Indian population as well as provide novel numbers on the prevalence of glaucoma and its patterns in one of the largest tertiary care hospitals in Egypt. These results will then be compared to patterns observed in other epidemiological studies done in other countries.
- Conditions
- Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India
- Being tested
- collection of data from patient files
- Keywords
- patterns, glaucoma, egypt, india, 2018
- Medical subject headings
- Glaucoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
collection of data from patient filesOther
recording of patient data and its input into an excel sheet from which statistics will be derived
| Study group | Role | What they receive |
|---|---|---|
| Group A | Patients referred to glaucoma sub-specialty clinics in Kasr Al-Aini Hospital, Cairo University, Egypt in the year 2018 Receives: Other: collection of data from patient files | |
| Group B | Patients referred to glaucoma sub-specialty clinics in Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology, Mumbai, India in the year 2018 Receives: Other: collection of data from patient files |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patterns of Glaucoma
Determining patterns of glaucoma seen in one year in glaucoma sub-specialty clinics in two countries: Egypt and India
Measured: 12 months starting january 1st, 2018 til December 31st, 2018
Demographic data
Determining demographic data with respect to age and gender in different types of glaucoma in each country
Measured: 12 months starting january 1st, 2018 til December 31st, 2018
Secondary outcomes (3)
Anti-glaucoma treatment
Determining details of anti-glaucoma treatment used in each country
Measured: 12 months starting january 1st, 2018 til December 31st, 2018
Positive family history
Determining percentage of patients with positive family history in each country
Measured: 12 months starting january 1st, 2018 til December 31st, 2018
Management decisions
Determining different management decisions taken by doctors in each country
Measured: 12 months starting january 1st, 2018 til December 31st, 2018
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2018
- Study start1 Jan 2018
- Primary completion31 Dec 2018 (estimated)
- Study completion31 Dec 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and IndiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 2,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kasr El Aini Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Sadguru Netra Chikitsalaya, Post Graduate Institute Of Ophthalmology (New SNC)
- Responsible party
- Principal investigator, Rana H. Amin, Kasr El Aini Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03491735
- Sponsor's protocol ID
- 12CM
- Status last verified
- Apr 2018
- First submitted
- 2 Apr 2018
- Last updated
- 9 Apr 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: statistics obtained from data collected
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018
- ClinicalTrials.gov ID
- NCT03491735
- Acronym / sponsor ID
- 12CM
- Conditions
- Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India
- Keywords
- patterns, glaucoma, egypt, india, 2018
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 2,500 participants (estimated)
- Lead sponsor
- Kasr El Aini HospitalUniversity, hospital or other
- Collaborators
- Sadguru Netra Chikitsalaya, Post Graduate Institute Of Ophthalmology (New SNC)
- Study start
- 1 Jan 2018 (actual)
- Primary completion
- 31 Dec 2018 (estimated)
- Study completion
- 31 Dec 2018 (estimated)
- First posted
- 9 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, we are aiming to identify the patterns of glaucoma observed and treated at Glaucoma Subspecialty Clinics of Kasr Al-Aini Hospital, Cairo University in Cairo, Egypt and corresponding clinics in Sadguru Netra Chikitsalaya Post Graduate Institute of Ophthalmology in Mumbai, Maharashtra, India during the year 2018. We are hoping that this study would provide an update on current statistics available on Indian population as well as provide novel numbers on the prevalence of glaucoma and its patterns in one of the largest tertiary care hospitals in Egypt. These results will then be compared to patterns observed in other epidemiological studies done in other countries.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | – | Other: collection of data from patient filesPatients referred to glaucoma sub-specialty clinics in Kasr Al-Aini Hospital, Cairo University, Egypt in the year 2018 |
| Group B | – | Other: collection of data from patient filesPatients referred to glaucoma sub-specialty clinics in Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology, Mumbai, India in the year 2018 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients referred to and following up in the glaucoma sub-specialty clinics in the year 2018 in two centres: Kasr Al-Aini Hospital in Cairo and Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology in India
Key inclusion criteria (1 listed)
- All patients referred to glaucoma sub-specialty clinics in the year 2018 in two centres: Kasr Al-Aini Hospital in Cairo and Sadguru Netra Chikitsalaya Postgraduate Institute of Ophthalmology in India
Key exclusion criteria (2 listed)
- Patients younger than 18 years old.
- Patients with incomplete examination data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| collection of data from patient filesrecording of patient data and its input into an excel sheet from which statistics will be derived | Other | Group A, Group B |
Primary outcome
Patterns of Glaucoma
Time frame: 12 months starting january 1st, 2018 til December 31st, 2018
Determining patterns of glaucoma seen in one year in glaucoma sub-specialty clinics in two countries: Egypt and India
Demographic data
Time frame: 12 months starting january 1st, 2018 til December 31st, 2018
Determining demographic data with respect to age and gender in different types of glaucoma in each country
3 secondary outcomes
Anti-glaucoma treatment
Time frame: 12 months starting january 1st, 2018 til December 31st, 2018
Positive family history
Time frame: 12 months starting january 1st, 2018 til December 31st, 2018
Management decisions
Time frame: 12 months starting january 1st, 2018 til December 31st, 2018
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2018.
- Individual participant dataSharing planned: Yes. statistics obtained from data collected
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India, run by Kasr El Aini Hospital at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt, India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Rana H Amin, M.Sc. (00201276020720, rana_hussein4@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patterns of Glaucoma (time frame: 12 months starting january 1st, 2018 til December 31st, 2018). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2018; AzTrials last refreshed its copy on 7 Nov 2026.